Breast cancer is the most common cause of cancer death in women worldwide. This malignancy is a complex disease, which is defi ned by an intrinsic heterogeneity on the histopathological and molecular level as well as response to therapy and outcome. In addition to classical histopathological features, breast cancer can be categorized into at least fi ve major subtypes based on comprehensive gene expression profi ling: luminal A, luminal B, basal-like, ERBB2-positive, and normal-like breast cancer. Genetically engineered mouse models can serve as tools to study the molecular underpinnings for this disease. Given the genetic complexity that drives the initiation and progression of individual breast cancer subtypes, it is evident that certain models can refl ect only particular aspects of this malignancy. In this book chapter, we will primarily focus on advances in modeling breast cancer at defi ned stages of carcinogenesis using genetically engineered mice. We will discuss the ability as well as shortcomings of these models to faithfully recapitulate the spectrum of human breast cancer subtypes.
- Cancer progression
- Molecular subtypes
- Mouse models
ASJC Scopus subject areas
- Agricultural and Biological Sciences(all)